Pyrrolopyrazine kinase inhibitors
US8329699B2 · kind B2 · utility
0Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2011 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | May 18, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I,wherein the variables Q and R1 and R2 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.